The U.S. Food and Drug Administration (FDA) published a report about tacrolimus oral capsules manufactured by Accord Healthcare Inc. Tacrolimus is a medication that helps prevent organ rejection in transplant patients.
If you are taking tacrolimus, do not stop taking it, even if you are taking the Accord product. You can find out if you are taking the Accord product by calling your pharmacy. You might also find this information on the label on your prescription bottle.
According to the FDA, if you are taking the Accord product, your trough levels, which is what we measure with routine lab testing, will be unchanged and the risk of rejection is not increased. However, there could be an increased risk of side effects.
Mayo Clinic recommends that you ask your pharmacy for a non-Accord product. If you are not experiencing any new or worsening side effects since your last refill, this can be at your next scheduled refill of your prescription. If you experience new or worsening side effects, ask your pharmacist to assist you in getting an early refill of a non-Accord product as soon as possible.
Continue to take the Accord product until another product is available for you, even if you are experiencing side effects. Stopping your tacrolimus for even a short period of time will increase your risk for rejection. If your pharmacy cannot give you tacrolimus manufactured by another company, please let your Mayo coordinator know. They will help you in the next steps to get your prescription.
New or worsening side effects to watch for may include an increase compared to normal of headache, tremor, blood pressure, or in very rare cases, seizure.
You can read more information about the FDA report on the FDA website. If the link doesn’t work, go to fda.gov and search for search tacrolimus or Accord Healthcare.